Lunasin reduces the susceptibility of IL-10 deficient mice to inflammatory bowel disease and modulates the activation of the NLRP3 inflammasome
Andrea Nieto-Veloza, Shan Hong, Matthew Winston Reeder, Mee‐Ja M. Sula, Doris H. D’Souza, Qixin Zhong, Vermont P. Día
Topics & Concepts
InflammasomeProinflammatory cytokineInflammatory bowel diseaseInflammationImmunologyIn vivoCaspase 1Interleukin 10CytokineMedicineBiologyDiseaseInternal medicineBiotechnologyInflammasome and immune disordersIL-33, ST2, and ILC PathwaysCholesterol and Lipid Metabolism